Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 289.30M | £ 1.05B | £ 232.70M | £ 1.60B | £ 415.50M |
Total Assets | £ 28.53B | £ 25.76B | £ 23.41B | £ 21.59B | £ 20.35B |
Total Debt | £ 9.37B | £ 9.03B | £ 9.11B | £ 9.41B | £ 10.06B |
Net Debt | £ 9.08B | £ 7.98B | £ 8.88B | £ 7.80B | £ 9.64B |
Total Liabilities | £ 18.69B | £ 16.59B | £ 16.32B | £ 14.91B | £ 15.16B |
Stockholders Equity | £ 9.79B | £ 9.13B | £ 7.09B | £ 6.68B | £ 5.19B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |